nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0852	0.318	CbGbCtD
Nimodipine—CACNA1S—pes—peripheral nervous system neoplasm	0.0448	0.271	CbGeAlD
Nimodipine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0391	0.146	CbGbCtD
Nimodipine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0358	0.134	CbGbCtD
Nimodipine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0357	0.133	CbGbCtD
Nimodipine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0332	0.124	CbGbCtD
Nimodipine—CACNA1D—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.032	0.193	CbGeAlD
Nimodipine—CACNA1D—cochlea—peripheral nervous system neoplasm	0.0162	0.098	CbGeAlD
Nimodipine—CACNA1D—internal ear—peripheral nervous system neoplasm	0.0153	0.0929	CbGeAlD
Nimodipine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0152	0.0569	CbGbCtD
Nimodipine—CACNB4—ganglion—peripheral nervous system neoplasm	0.0143	0.0865	CbGeAlD
Nimodipine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.014	0.0522	CbGbCtD
Nimodipine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00953	0.0356	CbGbCtD
Nimodipine—CACNB4—trigeminal ganglion—peripheral nervous system neoplasm	0.00702	0.0425	CbGeAlD
Nimodipine—CACNB3—trigeminal ganglion—peripheral nervous system neoplasm	0.00538	0.0326	CbGeAlD
Nimodipine—AHR—trigeminal ganglion—peripheral nervous system neoplasm	0.00398	0.0241	CbGeAlD
Nimodipine—AHR—parotid gland—peripheral nervous system neoplasm	0.00376	0.0227	CbGeAlD
Nimodipine—CACNB4—cerebellum—peripheral nervous system neoplasm	0.00306	0.0185	CbGeAlD
Nimodipine—NR3C2—trigeminal ganglion—peripheral nervous system neoplasm	0.00265	0.0161	CbGeAlD
Nimodipine—NR3C2—parotid gland—peripheral nervous system neoplasm	0.0025	0.0152	CbGeAlD
Nimodipine—CACNB1—cerebellum—peripheral nervous system neoplasm	0.00245	0.0148	CbGeAlD
Nimodipine—Clevidipine—BCHE—peripheral nervous system neoplasm	0.00241	0.351	CrCbGaD
Nimodipine—NR3C2—brainstem—peripheral nervous system neoplasm	0.00235	0.0142	CbGeAlD
Nimodipine—CACNB3—cerebellum—peripheral nervous system neoplasm	0.00235	0.0142	CbGeAlD
Nimodipine—AHR—cerebellum—peripheral nervous system neoplasm	0.00174	0.0105	CbGeAlD
Nimodipine—CACNB2—cerebellum—peripheral nervous system neoplasm	0.00158	0.00954	CbGeAlD
Nimodipine—CACNA1D—cerebellum—peripheral nervous system neoplasm	0.00138	0.00834	CbGeAlD
Nimodipine—CACNA1C—cerebellum—peripheral nervous system neoplasm	0.00127	0.0077	CbGeAlD
Nimodipine—CACNB3—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00122	0.00639	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00122	0.00638	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.00121	0.00635	CbGpPWpGaD
Nimodipine—CACNA1D—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.0012	0.00631	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00119	0.00622	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.00117	0.00614	CbGpPWpGaD
Nimodipine—NR3C2—cerebellum—peripheral nervous system neoplasm	0.00116	0.00701	CbGeAlD
Nimodipine—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.00107	0.00291	CcSEcCtD
Nimodipine—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.00107	0.00291	CcSEcCtD
Nimodipine—Myalgia—Melphalan—peripheral nervous system neoplasm	0.00106	0.00287	CcSEcCtD
Nimodipine—CACNA1C—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.00106	0.00555	CbGpPWpGaD
Nimodipine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00105	0.00551	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00104	0.00547	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00104	0.00547	CbGpPWpGaD
Nimodipine—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.00104	0.00282	CcSEcCtD
Nimodipine—AHR—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.00104	0.00546	CbGpPWpGaD
Nimodipine—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00103	0.00279	CcSEcCtD
Nimodipine—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.00279	CcSEcCtD
Nimodipine—CACNB2—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00102	0.00536	CbGpPWpGaD
Nimodipine—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00276	CcSEcCtD
Nimodipine—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00102	0.00276	CcSEcCtD
Nimodipine—CACNB3—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00102	0.00533	CbGpPWpGaD
Nimodipine—Oedema—Melphalan—peripheral nervous system neoplasm	0.00102	0.00275	CcSEcCtD
Nimodipine—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00102	0.00275	CcSEcCtD
Nimodipine—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00273	CcSEcCtD
Nimodipine—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00273	CcSEcCtD
Nimodipine—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00273	CcSEcCtD
Nimodipine—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00273	CcSEcCtD
Nimodipine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.001	0.00272	CcSEcCtD
Nimodipine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.001	0.00272	CcSEcCtD
Nimodipine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.001	0.00272	CcSEcCtD
Nimodipine—CACNB2—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.001	0.00524	CbGpPWpGaD
Nimodipine—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.000996	0.0027	CcSEcCtD
Nimodipine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000995	0.00269	CcSEcCtD
Nimodipine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000995	0.00269	CcSEcCtD
Nimodipine—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000995	0.00269	CcSEcCtD
Nimodipine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000992	0.00268	CcSEcCtD
Nimodipine—CACNB1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000989	0.00518	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000988	0.00518	CbGpPWpGaD
Nimodipine—CACNB3—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000988	0.00518	CbGpPWpGaD
Nimodipine—Hepatobiliary disease—Cisplatin—peripheral nervous system neoplasm	0.000986	0.00267	CcSEcCtD
Nimodipine—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.000982	0.00266	CcSEcCtD
Nimodipine—CACNB4—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000975	0.00511	CbGpPWpGaD
Nimodipine—CACNA1D—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.000969	0.00508	CbGpPWpGaD
Nimodipine—CACNB4—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	0.000967	0.00507	CbGpPWpGaD
Nimodipine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000962	0.0026	CcSEcCtD
Nimodipine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000962	0.0026	CcSEcCtD
Nimodipine—CACNB1—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000961	0.00504	CbGpPWpGaD
Nimodipine—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.00096	0.0026	CcSEcCtD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—GNAS—peripheral nervous system neoplasm	0.000957	0.00502	CbGpPWpGaD
Nimodipine—Phosphatase alkaline increased—Epirubicin—peripheral nervous system neoplasm	0.000957	0.00259	CcSEcCtD
Nimodipine—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.000953	0.00258	CcSEcCtD
Nimodipine—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.000953	0.00258	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000952	0.00499	CbGpPWpGaD
Nimodipine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00095	0.00257	CcSEcCtD
Nimodipine—CACNA1D—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.000947	0.00496	CbGpPWpGaD
Nimodipine—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000946	0.00256	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000938	0.00254	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000938	0.00254	CcSEcCtD
Nimodipine—CACNA1F—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000931	0.00488	CbGpPWpGaD
Nimodipine—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000931	0.00252	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000926	0.00251	CcSEcCtD
Nimodipine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000925	0.0025	CcSEcCtD
Nimodipine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000918	0.00248	CcSEcCtD
Nimodipine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000918	0.00248	CcSEcCtD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.000916	0.0048	CbGpPWpGaD
Nimodipine—Fluid retention—Epirubicin—peripheral nervous system neoplasm	0.000908	0.00246	CcSEcCtD
Nimodipine—Nisoldipine—ABCB1—peripheral nervous system neoplasm	0.000906	0.132	CrCbGaD
Nimodipine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000906	0.00245	CcSEcCtD
Nimodipine—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.000903	0.00244	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000896	0.00243	CcSEcCtD
Nimodipine—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000893	0.00468	CbGpPWpGaD
Nimodipine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000889	0.00241	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000889	0.00241	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Doxorubicin—peripheral nervous system neoplasm	0.000885	0.0024	CcSEcCtD
Nimodipine—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000884	0.00239	CcSEcCtD
Nimodipine—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000878	0.00238	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000877	0.00237	CcSEcCtD
Nimodipine—CACNA1S—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000869	0.00455	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000869	0.00455	CbGpPWpGaD
Nimodipine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000868	0.00235	CcSEcCtD
Nimodipine—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.000868	0.00235	CcSEcCtD
Nimodipine—CACNA1C—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.000852	0.00446	CbGpPWpGaD
Nimodipine—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000851	0.0023	CcSEcCtD
Nimodipine—Nitrendipine—ABCB1—peripheral nervous system neoplasm	0.000848	0.123	CrCbGaD
Nimodipine—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000845	0.00229	CcSEcCtD
Nimodipine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000845	0.00229	CcSEcCtD
Nimodipine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000842	0.00228	CcSEcCtD
Nimodipine—Fluid retention—Doxorubicin—peripheral nervous system neoplasm	0.000841	0.00228	CcSEcCtD
Nimodipine—CACNB3—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000834	0.00437	CbGpPWpGaD
Nimodipine—CACNA1C—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.000832	0.00436	CbGpPWpGaD
Nimodipine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000825	0.00223	CcSEcCtD
Nimodipine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000824	0.00223	CcSEcCtD
Nimodipine—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000814	0.0022	CcSEcCtD
Nimodipine—CACNB1—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000812	0.00425	CbGpPWpGaD
Nimodipine—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.000806	0.00218	CcSEcCtD
Nimodipine—CACNB2—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.000805	0.00422	CbGpPWpGaD
Nimodipine—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.000799	0.00216	CcSEcCtD
Nimodipine—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000796	0.00215	CcSEcCtD
Nimodipine—Flushing—Etoposide—peripheral nervous system neoplasm	0.000796	0.00215	CcSEcCtD
Nimodipine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000795	0.00215	CcSEcCtD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.000786	0.00412	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000785	0.00411	CbGpPWpGaD
Nimodipine—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000784	0.00212	CcSEcCtD
Nimodipine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000783	0.00212	CcSEcCtD
Nimodipine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00078	0.00211	CcSEcCtD
Nimodipine—CACNB3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000779	0.00408	CbGpPWpGaD
Nimodipine—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000778	0.00211	CcSEcCtD
Nimodipine—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000774	0.0021	CcSEcCtD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	0.000773	0.00405	CbGpPWpGaD
Nimodipine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000767	0.00208	CcSEcCtD
Nimodipine—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.000766	0.00207	CcSEcCtD
Nimodipine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000765	0.00207	CcSEcCtD
Nimodipine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000765	0.00207	CcSEcCtD
Nimodipine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000764	0.00207	CcSEcCtD
Nimodipine—CACNA1D—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.000762	0.00399	CbGpPWpGaD
Nimodipine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000761	0.00206	CcSEcCtD
Nimodipine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000759	0.00205	CcSEcCtD
Nimodipine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000759	0.00205	CcSEcCtD
Nimodipine—CACNB1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000758	0.00397	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000754	0.00204	CcSEcCtD
Nimodipine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000753	0.00204	CcSEcCtD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	0.000752	0.00394	CbGpPWpGaD
Nimodipine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000752	0.00204	CcSEcCtD
Nimodipine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000749	0.00203	CcSEcCtD
Nimodipine—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000747	0.00391	CbGpPWpGaD
Nimodipine—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000746	0.00202	CcSEcCtD
Nimodipine—CACNB4—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000745	0.0039	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000745	0.0039	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.000744	0.0039	CbGpPWpGaD
Nimodipine—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.000739	0.002	CcSEcCtD
Nimodipine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000737	0.002	CcSEcCtD
Nimodipine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000736	0.00199	CcSEcCtD
Nimodipine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000734	0.00199	CcSEcCtD
Nimodipine—Amlodipine—ABCB1—peripheral nervous system neoplasm	0.00073	0.106	CrCbGaD
Nimodipine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000729	0.00197	CcSEcCtD
Nimodipine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000728	0.00197	CcSEcCtD
Nimodipine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000728	0.00197	CcSEcCtD
Nimodipine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000727	0.00197	CcSEcCtD
Nimodipine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000719	0.00195	CcSEcCtD
Nimodipine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000717	0.00194	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000711	0.00192	CcSEcCtD
Nimodipine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00071	0.00192	CcSEcCtD
Nimodipine—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000709	0.00192	CcSEcCtD
Nimodipine—CACNB4—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	0.000708	0.00371	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000705	0.0037	CbGpPWpGaD
Nimodipine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000704	0.00191	CcSEcCtD
Nimodipine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000704	0.00191	CcSEcCtD
Nimodipine—CACNA1S—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000704	0.00369	CbGpPWpGaD
Nimodipine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000703	0.0019	CcSEcCtD
Nimodipine—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.000697	0.00189	CcSEcCtD
Nimodipine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000696	0.00188	CcSEcCtD
Nimodipine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000695	0.00188	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000695	0.00188	CcSEcCtD
Nimodipine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000693	0.00188	CcSEcCtD
Nimodipine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00069	0.00187	CcSEcCtD
Nimodipine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000686	0.00186	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000685	0.00185	CcSEcCtD
Nimodipine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000681	0.00184	CcSEcCtD
Nimodipine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000681	0.00184	CcSEcCtD
Nimodipine—Felodipine—ABCB1—peripheral nervous system neoplasm	0.000675	0.0983	CrCbGaD
Nimodipine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000674	0.00182	CcSEcCtD
Nimodipine—CACNA1C—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.00067	0.00351	CbGpPWpGaD
Nimodipine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000665	0.0018	CcSEcCtD
Nimodipine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00066	0.00179	CcSEcCtD
Nimodipine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000655	0.00177	CcSEcCtD
Nimodipine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000655	0.00177	CcSEcCtD
Nimodipine—Rash—Topotecan—peripheral nervous system neoplasm	0.000654	0.00177	CcSEcCtD
Nimodipine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000654	0.00177	CcSEcCtD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.000654	0.00343	CbGpPWpGaD
Nimodipine—Nifedipine—ABCB1—peripheral nervous system neoplasm	0.000652	0.095	CrCbGaD
Nimodipine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000652	0.00176	CcSEcCtD
Nimodipine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000651	0.00176	CcSEcCtD
Nimodipine—Headache—Topotecan—peripheral nervous system neoplasm	0.00065	0.00176	CcSEcCtD
Nimodipine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000649	0.00176	CcSEcCtD
Nimodipine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000649	0.00176	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000649	0.00176	CcSEcCtD
Nimodipine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000649	0.00176	CcSEcCtD
Nimodipine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000649	0.00176	CcSEcCtD
Nimodipine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000649	0.00176	CcSEcCtD
Nimodipine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000646	0.00175	CcSEcCtD
Nimodipine—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000645	0.00175	CcSEcCtD
Nimodipine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000645	0.00175	CcSEcCtD
Nimodipine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000645	0.00175	CcSEcCtD
Nimodipine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000644	0.00174	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000643	0.00174	CcSEcCtD
Nimodipine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000643	0.00174	CcSEcCtD
Nimodipine—Nicardipine—ABCB1—peripheral nervous system neoplasm	0.000642	0.0936	CrCbGaD
Nimodipine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000641	0.00174	CcSEcCtD
Nimodipine—Rash—Melphalan—peripheral nervous system neoplasm	0.000641	0.00173	CcSEcCtD
Nimodipine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00064	0.00173	CcSEcCtD
Nimodipine—CACNB2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000621	0.00326	CbGpPWpGaD
Nimodipine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000621	0.00168	CcSEcCtD
Nimodipine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00062	0.00168	CcSEcCtD
Nimodipine—CACNA1C—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00062	0.00325	CbGpPWpGaD
Nimodipine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000616	0.00167	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000613	0.00166	CcSEcCtD
Nimodipine—NR3C2—Gene Expression—EED—peripheral nervous system neoplasm	0.000612	0.00321	CbGpPWpGaD
Nimodipine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000612	0.00166	CcSEcCtD
Nimodipine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000612	0.00166	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000606	0.00164	CcSEcCtD
Nimodipine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000604	0.00163	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.0006	0.00314	CbGpPWpGaD
Nimodipine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000596	0.00161	CcSEcCtD
Nimodipine—CACNB3—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000595	0.00312	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000595	0.00312	CbGpPWpGaD
Nimodipine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000594	0.00161	CcSEcCtD
Nimodipine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000593	0.00161	CcSEcCtD
Nimodipine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000593	0.0016	CcSEcCtD
Nimodipine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000589	0.00159	CcSEcCtD
Nimodipine—CACNA1S—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000583	0.00306	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000579	0.00304	CbGpPWpGaD
Nimodipine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000576	0.00302	CbGpPWpGaD
Nimodipine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000576	0.00156	CcSEcCtD
Nimodipine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000575	0.00156	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000574	0.00155	CcSEcCtD
Nimodipine—CACNA1D—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000572	0.003	CbGpPWpGaD
Nimodipine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000569	0.00154	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000567	0.00153	CcSEcCtD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	0.000566	0.00296	CbGpPWpGaD
Nimodipine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000554	0.0015	CcSEcCtD
Nimodipine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000552	0.00149	CcSEcCtD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	0.000551	0.00289	CbGpPWpGaD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	0.00055	0.00288	CbGpPWpGaD
Nimodipine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000543	0.00147	CcSEcCtD
Nimodipine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000535	0.00145	CcSEcCtD
Nimodipine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000534	0.00145	CcSEcCtD
Nimodipine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000531	0.00144	CcSEcCtD
Nimodipine—CACNB3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00053	0.00278	CbGpPWpGaD
Nimodipine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000526	0.00142	CcSEcCtD
Nimodipine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000522	0.00141	CcSEcCtD
Nimodipine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000516	0.0014	CcSEcCtD
Nimodipine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000514	0.00139	CcSEcCtD
Nimodipine—CACNB2—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00051	0.00267	CbGpPWpGaD
Nimodipine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000506	0.00137	CcSEcCtD
Nimodipine—CACNA1C—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000502	0.00263	CbGpPWpGaD
Nimodipine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.0005	0.00135	CcSEcCtD
Nimodipine—CACNB4—Axon guidance—MET—peripheral nervous system neoplasm	0.000499	0.00261	CbGpPWpGaD
Nimodipine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000497	0.00135	CcSEcCtD
Nimodipine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000496	0.00134	CcSEcCtD
Nimodipine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000492	0.00133	CcSEcCtD
Nimodipine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000492	0.00133	CcSEcCtD
Nimodipine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00049	0.00133	CcSEcCtD
Nimodipine—NR3C2—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000489	0.00256	CbGpPWpGaD
Nimodipine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000489	0.00132	CcSEcCtD
Nimodipine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000489	0.00132	CcSEcCtD
Nimodipine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000483	0.00131	CcSEcCtD
Nimodipine—CACNA1D—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000483	0.00253	CbGpPWpGaD
Nimodipine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000481	0.0013	CcSEcCtD
Nimodipine—CACNB2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00048	0.00251	CbGpPWpGaD
Nimodipine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000478	0.00129	CcSEcCtD
Nimodipine—CACNB2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000476	0.00249	CbGpPWpGaD
Nimodipine—Rash—Vincristine—peripheral nervous system neoplasm	0.000474	0.00128	CcSEcCtD
Nimodipine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000474	0.00128	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000473	0.00248	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	0.000472	0.00248	CbGpPWpGaD
Nimodipine—Headache—Vincristine—peripheral nervous system neoplasm	0.000471	0.00127	CcSEcCtD
Nimodipine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.00127	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000468	0.00245	CbGpPWpGaD
Nimodipine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000463	0.00125	CcSEcCtD
Nimodipine—CACNB4—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000461	0.00242	CbGpPWpGaD
Nimodipine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000455	0.00123	CcSEcCtD
Nimodipine—CACNA1D—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000454	0.00238	CbGpPWpGaD
Nimodipine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.00123	CcSEcCtD
Nimodipine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000449	0.00121	CcSEcCtD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	0.000447	0.00234	CbGpPWpGaD
Nimodipine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000447	0.00121	CcSEcCtD
Nimodipine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000446	0.00121	CcSEcCtD
Nimodipine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000446	0.00121	CcSEcCtD
Nimodipine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.0012	CcSEcCtD
Nimodipine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000436	0.00118	CcSEcCtD
Nimodipine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000434	0.00117	CcSEcCtD
Nimodipine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000431	0.00117	CcSEcCtD
Nimodipine—CACNA1S—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000424	0.00222	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000424	0.00222	CbGpPWpGaD
Nimodipine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000423	0.00114	CcSEcCtD
Nimodipine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000419	0.00113	CcSEcCtD
Nimodipine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000419	0.00113	CcSEcCtD
Nimodipine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000417	0.00113	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000416	0.00218	CbGpPWpGaD
Nimodipine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.00112	CcSEcCtD
Nimodipine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.00112	CcSEcCtD
Nimodipine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.00109	CcSEcCtD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	0.000403	0.00211	CbGpPWpGaD
Nimodipine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000403	0.00109	CcSEcCtD
Nimodipine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000402	0.00109	CcSEcCtD
Nimodipine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.00109	CcSEcCtD
Nimodipine—CACNA1C—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000399	0.00209	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—MET—peripheral nervous system neoplasm	0.000399	0.00209	CbGpPWpGaD
Nimodipine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000395	0.00107	CcSEcCtD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	0.000393	0.00206	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—MET—peripheral nervous system neoplasm	0.000388	0.00203	CbGpPWpGaD
Nimodipine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000387	0.00105	CcSEcCtD
Nimodipine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000387	0.00105	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000384	0.00201	CbGpPWpGaD
Nimodipine—Rash—Etoposide—peripheral nervous system neoplasm	0.000384	0.00104	CcSEcCtD
Nimodipine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000384	0.00104	CcSEcCtD
Nimodipine—CACNB3—Metabolism—GNS—peripheral nervous system neoplasm	0.000383	0.00201	CbGpPWpGaD
Nimodipine—Headache—Etoposide—peripheral nervous system neoplasm	0.000382	0.00103	CcSEcCtD
Nimodipine—CACNA1S—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000374	0.00196	CbGpPWpGaD
Nimodipine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.00101	CcSEcCtD
Nimodipine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00037	0.001	CcSEcCtD
Nimodipine—CACNB3—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000369	0.00193	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—NME1—peripheral nervous system neoplasm	0.000368	0.00193	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000365	0.00191	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000364	0.00191	CbGpPWpGaD
Nimodipine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000362	0.000979	CcSEcCtD
Nimodipine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000978	CcSEcCtD
Nimodipine—CACNB1—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000359	0.00188	CbGpPWpGaD
Nimodipine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000968	CcSEcCtD
Nimodipine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000964	CcSEcCtD
Nimodipine—CACNB4—Developmental Biology—MET—peripheral nervous system neoplasm	0.000356	0.00187	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—COX2—peripheral nervous system neoplasm	0.000354	0.00185	CbGpPWpGaD
Nimodipine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000347	0.00182	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	0.000346	0.00181	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000344	0.00181	CbGpPWpGaD
Nimodipine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000926	CcSEcCtD
Nimodipine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000924	CcSEcCtD
Nimodipine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000906	CcSEcCtD
Nimodipine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000905	CcSEcCtD
Nimodipine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000905	CcSEcCtD
Nimodipine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000902	CcSEcCtD
Nimodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000331	0.00173	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000893	CcSEcCtD
Nimodipine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000892	CcSEcCtD
Nimodipine—CACNB4—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000329	0.00173	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	0.000327	0.00171	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000325	0.0017	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000324	0.0017	CbGpPWpGaD
Nimodipine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000864	CcSEcCtD
Nimodipine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000855	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000842	CcSEcCtD
Nimodipine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000839	CcSEcCtD
Nimodipine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000837	CcSEcCtD
Nimodipine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000835	CcSEcCtD
Nimodipine—CACNA1D—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000307	0.00161	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000306	0.0016	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000827	CcSEcCtD
Nimodipine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000824	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000303	0.00159	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000303	0.00159	CbGpPWpGaD
Nimodipine—CACNB4—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000299	0.00156	CbGpPWpGaD
Nimodipine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000799	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000798	CcSEcCtD
Nimodipine—CACNB3—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000291	0.00153	CbGpPWpGaD
Nimodipine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000779	CcSEcCtD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	0.000288	0.00151	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MET—peripheral nervous system neoplasm	0.000285	0.00149	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MET—peripheral nervous system neoplasm	0.000284	0.00149	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000284	0.00149	CbGpPWpGaD
Nimodipine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000762	CcSEcCtD
Nimodipine—CACNB4—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000277	0.00145	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MET—peripheral nervous system neoplasm	0.000277	0.00145	CbGpPWpGaD
Nimodipine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000738	CcSEcCtD
Nimodipine—CACNA1C—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00027	0.00141	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000267	0.0014	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000263	0.00138	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000263	0.00138	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.00026	0.00136	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000256	0.00134	CbGpPWpGaD
Nimodipine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000681	CcSEcCtD
Nimodipine—CACNB2—Axon guidance—MET—peripheral nervous system neoplasm	0.000244	0.00128	CbGpPWpGaD
Nimodipine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000654	CcSEcCtD
Nimodipine—CACNB3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000239	0.00125	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GNS—peripheral nervous system neoplasm	0.000234	0.00123	CbGpPWpGaD
Nimodipine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000632	CcSEcCtD
Nimodipine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.00063	CcSEcCtD
Nimodipine—CACNB3—Metabolism—ENO2—peripheral nervous system neoplasm	0.000232	0.00122	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000232	0.00122	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MET—peripheral nervous system neoplasm	0.000231	0.00121	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000229	0.0012	CbGpPWpGaD
Nimodipine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000611	CcSEcCtD
Nimodipine—CACNB2—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000225	0.00118	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NME1—peripheral nervous system neoplasm	0.000225	0.00118	CbGpPWpGaD
Nimodipine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000605	CcSEcCtD
Nimodipine—CACNA1D—Metabolism—GNS—peripheral nervous system neoplasm	0.000222	0.00116	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000222	0.00116	CbGpPWpGaD
Nimodipine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000588	CcSEcCtD
Nimodipine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000585	CcSEcCtD
Nimodipine—CACNB2—Metabolism—COX2—peripheral nervous system neoplasm	0.000216	0.00113	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000216	0.00113	CbGpPWpGaD
Nimodipine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000583	CcSEcCtD
Nimodipine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000582	CcSEcCtD
Nimodipine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000579	CcSEcCtD
Nimodipine—CACNA1D—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000213	0.00112	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NME1—peripheral nervous system neoplasm	0.000213	0.00111	CbGpPWpGaD
Nimodipine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000565	CcSEcCtD
Nimodipine—CACNB3—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000208	0.00109	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000208	0.00109	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—COX2—peripheral nervous system neoplasm	0.000205	0.00107	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000203	0.00106	CbGpPWpGaD
Nimodipine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000549	CcSEcCtD
Nimodipine—CACNA1S—Developmental Biology—MET—peripheral nervous system neoplasm	0.000203	0.00106	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MET—peripheral nervous system neoplasm	0.000203	0.00106	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000202	0.00106	CbGpPWpGaD
Nimodipine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000544	CcSEcCtD
Nimodipine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000539	CcSEcCtD
Nimodipine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000539	CcSEcCtD
Nimodipine—CACNB4—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000198	0.00104	CbGpPWpGaD
Nimodipine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000536	CcSEcCtD
Nimodipine—CACNB3—Metabolism—BCHE—peripheral nervous system neoplasm	0.000196	0.00103	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GNS—peripheral nervous system neoplasm	0.000195	0.00102	CbGpPWpGaD
Nimodipine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000508	CcSEcCtD
Nimodipine—CACNA1S—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000188	0.000983	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000187	0.000982	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000187	0.000981	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NME1—peripheral nervous system neoplasm	0.000187	0.000979	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TH—peripheral nervous system neoplasm	0.000185	0.000967	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000183	0.000958	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—COX2—peripheral nervous system neoplasm	0.00018	0.000942	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000178	0.000933	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000178	0.000932	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000177	0.000926	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MET—peripheral nervous system neoplasm	0.000174	0.000911	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000169	0.000884	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MET—peripheral nervous system neoplasm	0.000165	0.000863	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000162	0.00085	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000161	0.000843	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000158	0.000829	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000158	0.000828	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000158	0.000827	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000154	0.000807	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000152	0.000798	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GNAS—peripheral nervous system neoplasm	0.000151	0.000789	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000148	0.000777	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000148	0.000776	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000148	0.000775	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000146	0.000764	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000145	0.000759	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MET—peripheral nervous system neoplasm	0.000145	0.000758	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000142	0.000744	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.000141	0.000737	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000135	0.00071	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ENO2—peripheral nervous system neoplasm	0.000134	0.000704	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000134	0.000701	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000128	0.000672	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000128	0.00067	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000127	0.000666	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.00012	0.000631	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—BCHE—peripheral nervous system neoplasm	0.00012	0.000628	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000119	0.000625	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ENO2—peripheral nervous system neoplasm	0.000118	0.000619	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000116	0.000607	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000116	0.000606	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000114	0.000599	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—BCHE—peripheral nervous system neoplasm	0.000114	0.000595	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000113	0.000591	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000113	0.000591	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TH—peripheral nervous system neoplasm	0.000113	0.000591	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000113	0.00059	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000112	0.000585	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000108	0.000568	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TH—peripheral nervous system neoplasm	0.000107	0.000559	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000106	0.000554	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000102	0.000536	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—BCHE—peripheral nervous system neoplasm	9.98e-05	0.000523	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—AKT1—peripheral nervous system neoplasm	9.94e-05	0.000521	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—HRAS—peripheral nervous system neoplasm	9.91e-05	0.000519	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NRAS—peripheral nervous system neoplasm	9.67e-05	0.000507	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.52e-05	0.000499	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—HRAS—peripheral nervous system neoplasm	9.39e-05	0.000492	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TH—peripheral nervous system neoplasm	9.38e-05	0.000491	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GNAS—peripheral nervous system neoplasm	9.2e-05	0.000482	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NRAS—peripheral nervous system neoplasm	9.15e-05	0.00048	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ABCB1—peripheral nervous system neoplasm	9.03e-05	0.000473	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GNAS—peripheral nervous system neoplasm	8.71e-05	0.000457	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	8.63e-05	0.000452	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ABCB1—peripheral nervous system neoplasm	8.55e-05	0.000448	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	8.27e-05	0.000433	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HRAS—peripheral nervous system neoplasm	8.25e-05	0.000432	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—HRAS—peripheral nervous system neoplasm	8.25e-05	0.000432	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.21e-05	0.00043	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NRAS—peripheral nervous system neoplasm	8.04e-05	0.000422	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	7.96e-05	0.000417	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GNAS—peripheral nervous system neoplasm	7.66e-05	0.000401	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ABCB1—peripheral nervous system neoplasm	7.51e-05	0.000394	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—peripheral nervous system neoplasm	7.28e-05	0.000382	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HRAS—peripheral nervous system neoplasm	7.07e-05	0.000371	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—peripheral nervous system neoplasm	6.77e-05	0.000355	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HRAS—peripheral nervous system neoplasm	6.7e-05	0.000351	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—peripheral nervous system neoplasm	6.24e-05	0.000327	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.91e-05	0.00031	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.88e-05	0.000308	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.55e-05	0.000291	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	5.23e-05	0.000274	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.2e-05	0.000272	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—peripheral nervous system neoplasm	4.69e-05	0.000246	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	4.42e-05	0.000231	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.21e-05	0.000221	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	4.15e-05	0.000218	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—peripheral nervous system neoplasm	4.07e-05	0.000213	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	4.01e-05	0.00021	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.84e-05	0.000201	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	3.7e-05	0.000194	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	3.39e-05	0.000178	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	3.33e-05	0.000174	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—peripheral nervous system neoplasm	2.48e-05	0.00013	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.43e-05	0.000127	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—peripheral nervous system neoplasm	2.35e-05	0.000123	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—peripheral nervous system neoplasm	2.07e-05	0.000108	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.05e-05	0.000108	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.96e-05	0.000103	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.93e-05	0.000101	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.58e-05	8.26e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.55e-05	8.1e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	9.15e-06	4.79e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	4.25e-06	2.23e-05	CbGpPWpGaD
